From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

ASHM launches the Asia Pacific Webinar Series to commemorate World AIDS Day

Share the link to this page with others to keep them informed

To commemorate World AIDS Day 2022, ASHM is launching the Asia Pacific Webinar Series.  The first webinar of the series examines steps needed to achieve triple elimination of mother-to-child transmission of HIV, viral hepatitis and syphilis in Asia and the Pacific. This webinar was recorded as part of a live triple elimination event held for ASHM members and friends at the Doherty Institute on the 14th of November in Melbourne. The event was hosted by Professor Benjamin Cowie, Director of the WHO Collaborating Centre for Viral Hepatitis at the Doherty Institute and panellists from DFAT, WHO Geneva, the Alola Foundation and Hepatitis B Voices Australia.

The webinar series is sponsored by Viatris and Gilead Sciences.

To access the webinars from the ASHM’s Asia Pacific Webinar Series for 2023, click here: https://ashm.org.au/global/asia-pacific-webinar-series/

To read more about ASHM’s Supporting Triple Elimination in Papua New Guinea and Timor-Leste Project, including how you can donate to the project, click here: Supporting Triple Elimination in Papua New Guinea and Timor-Leste (STEPT) Project – ASHM